150 related articles for article (PubMed ID: 18591774)
1. Angiotensin II regulates liver regeneration via type 1 receptor following partial hepatectomy in mice.
Yayama K; Miyagi R; Sugiyama K; Sugaya T; Fukamizu A; Okamoto H
Biol Pharm Bull; 2008 Jul; 31(7):1356-61. PubMed ID: 18591774
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
Yayama K; Sugiyama K; Miyagi R; Okamoto H
Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
4. Effect of adrenotensin on cell proliferation is mediated by angiotensin II in cultured rat mesangial cells.
Xue H; Yuan P; Zhou L; Yao T; Huang Y; Lu LM
Acta Pharmacol Sin; 2009 Aug; 30(8):1132-7. PubMed ID: 19597528
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice.
Li XC; Navar LG; Shao Y; Zhuo JL
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F586-93. PubMed ID: 17537986
[TBL] [Abstract][Full Text] [Related]
6. Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.
Kyuden Y; Ito T; Masaki T; Yorioka N; Kohno N
Perit Dial Int; 2005; 25(5):483-91. PubMed ID: 16178483
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II increases adipose angiotensinogen expression.
Lu H; Boustany-Kari CM; Daugherty A; Cassis LA
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1280-7. PubMed ID: 17213477
[TBL] [Abstract][Full Text] [Related]
8. Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.
Brown NJ; Bradford J; Wang Z; Lea W; Ma L; Ma J; Vaughan DE; Fogo AB
Kidney Int; 2007 Jul; 72(1):72-81. PubMed ID: 17429342
[TBL] [Abstract][Full Text] [Related]
9. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of AT1a receptor-mediated uptake of angiotensin II by proximal tubule cells: a novel role of the multiligand endocytic receptor megalin.
Li XC; Zhuo JL
Am J Physiol Renal Physiol; 2014 Jul; 307(2):F222-33. PubMed ID: 24740791
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
[TBL] [Abstract][Full Text] [Related]
14. Role of the spleen in liver regeneration in relation to transforming growth factor-β1 and hepatocyte growth factor.
Lee SC; Jeong HJ; Choi BJ; Kim SJ
J Surg Res; 2015 Jun; 196(2):270-7. PubMed ID: 25862490
[TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
16. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1.
Kim YH; Ryu JM; Lee YJ; Han HJ
J Cell Physiol; 2010 May; 223(2):397-407. PubMed ID: 20112290
[TBL] [Abstract][Full Text] [Related]
19. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
20. In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice.
Li XC; Zhuo JL
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F293-302. PubMed ID: 18045833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
